Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,100,793
+$2,993,106 QoQ
Shares Held
297,848
+22.4% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 286 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IDYA ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in IDYA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,100,793 297,848
2026-03-31 $8,107,687 243,328
2025-12-31 $8,854,897 256,144
2025-09-30 $6,612,246 243,008
2025-06-30 $4,564,155 217,134
2025-03-31 $2,773,984 169,352
2024-12-31 $3,868,337 150,519
2024-09-30 $4,866,427 153,612
2024-06-30 $5,239,253 149,224
2024-03-31 $5,496,056 125,252
2023-12-31 $612,722 17,221
2023-09-30 $968,336 35,891
2023-06-30 $1,014,330 43,163
2023-03-31 $406,517 29,608
2022-12-31 $9,393 517
2022-09-30 $23,826 1,597
2022-06-30 $19,319 1,400
2022-03-31 $365,598 32,672
2021-12-31 $985,929 41,706
2021-09-30 $593,457 23,282
2021-06-30 $529,262 25,215
2021-03-31 $471,409 20,060
2020-12-31 $517,482 36,963
2020-09-30 $163,958 13,054
2020-06-30 $95,434 6,716
2020-03-31 $144 35